|
WO1998049321A2
(en)
|
1997-04-28 |
1998-11-05 |
Rhone-Poulenc Rorer S.A. |
Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
|
|
SE510650C2
(sv)
*
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
|
FR2794771B1
(fr)
|
1999-06-11 |
2001-08-10 |
Aventis Pharma Sa |
Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
|
|
US6853921B2
(en)
|
1999-07-20 |
2005-02-08 |
Halliburton Energy Services, Inc. |
System and method for real time reservoir management
|
|
US6266619B1
(en)
*
|
1999-07-20 |
2001-07-24 |
Halliburton Energy Services, Inc. |
System and method for real time reservoir management
|
|
GB9920548D0
(en)
*
|
1999-08-31 |
1999-11-03 |
Rhone Poulenc Rorer Sa |
Treatment of hepatocellular carcinoma
|
|
US6891050B2
(en)
*
|
2001-08-10 |
2005-05-10 |
Dabur India Limited |
Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
|
|
US6881852B2
(en)
*
|
2002-02-05 |
2005-04-19 |
Dabur India Limited |
Process of purification of paclitaxel and docetaxel
|
|
US7247738B2
(en)
*
|
2002-05-07 |
2007-07-24 |
Dabur India Limited |
Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
|
|
US6900342B2
(en)
*
|
2002-05-10 |
2005-05-31 |
Dabur India Limited |
Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
|
|
US6838569B2
(en)
*
|
2002-12-16 |
2005-01-04 |
Dabur India Limited |
Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
|
|
US7584165B2
(en)
*
|
2003-01-30 |
2009-09-01 |
Landmark Graphics Corporation |
Support apparatus, method and system for real time operations and maintenance
|
|
US8703982B2
(en)
|
2003-03-17 |
2014-04-22 |
Phyton Holdings Llc |
Purification of taxanes
|
|
CN1268619C
(zh)
*
|
2003-05-08 |
2006-08-09 |
上海迪赛诺化学制药有限公司 |
多烯紫杉醇三水化合物的制备方法
|
|
FR2859996B1
(fr)
*
|
2003-09-19 |
2006-02-03 |
Aventis Pharma Sa |
Solvat acetonique du dimethoxy docetaxel et son procede de preparation
|
|
WO2005061474A1
(en)
|
2003-12-12 |
2005-07-07 |
Quiral Química Do Brasil |
Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions
|
|
US7142986B2
(en)
*
|
2005-02-01 |
2006-11-28 |
Smith International, Inc. |
System for optimizing drilling in real time
|
|
CN100420681C
(zh)
*
|
2005-04-29 |
2008-09-24 |
上海奥锐特国际贸易有限公司 |
多烯紫杉醇三水物的制备方法
|
|
PT3311805T
(pt)
*
|
2005-08-31 |
2020-04-21 |
Abraxis Bioscience Llc |
Composições compreendendo agentes farmacêuticos pouco hidrossolúveis e agentes antimicrobianos
|
|
BRPI0615292A8
(pt)
*
|
2005-08-31 |
2018-03-06 |
Abraxis Bioscience Llc |
composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
|
|
WO2007044950A2
(en)
*
|
2005-10-12 |
2007-04-19 |
Sicor, Inc. |
Crystalline forms of docetaxel and processes for their preparation
|
|
KR100995390B1
(ko)
|
2006-01-02 |
2010-11-19 |
주식회사 삼양제넥스 |
무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
|
|
MX2008009308A
(es)
*
|
2006-01-20 |
2008-10-03 |
Landmark Graphics Corp |
Administracion del sistema de produccion dinamica.
|
|
US20100160653A1
(en)
*
|
2006-03-21 |
2010-06-24 |
Dr. Reddy's Laboratories Ltd. |
Docetaxel polymorphs and processes
|
|
EP2094084A4
(en)
*
|
2006-10-20 |
2010-01-13 |
Scinopharm Singapore Pte Ltd |
PROCESS FOR PREPARING CRYSTALLINE WATER-FREE DOCETAXEL
|
|
KR100868116B1
(ko)
|
2007-04-09 |
2008-11-10 |
한미약품 주식회사 |
도세탁셀·모노프로필렌글라이콜 내포화합물 및 이의제조방법
|
|
KR100878455B1
(ko)
|
2007-04-10 |
2009-01-13 |
한미약품 주식회사 |
안정한 무수결정형 도세탁셀 및 이의 제조방법
|
|
WO2009006590A2
(en)
*
|
2007-07-04 |
2009-01-08 |
Dr. Reddy's Laboratories Ltd. |
Docetaxel process and polymorphs
|
|
ES2389518T3
(es)
*
|
2008-01-18 |
2012-10-26 |
Indena S.P.A. |
Formas sólidas de ortataxel
|
|
EP2080763A1
(en)
*
|
2008-01-18 |
2009-07-22 |
INDENA S.p.A. |
Crystalline form I of ortataxel
|
|
PL388144A1
(pl)
|
2009-05-29 |
2010-12-06 |
Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością |
Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
|
|
US8686165B2
(en)
*
|
2009-11-04 |
2014-04-01 |
Emcure Pharmaceuticals Limited |
Process for preparation of taxane derivatives
|
|
KR101752944B1
(ko)
|
2010-05-03 |
2017-07-03 |
테이코쿠 팔마 유에스에이, 인코포레이티드 |
비수성의 탁산 프로에멀젼 제제, 및 그의 제조 및 사용 방법
|
|
WO2012160568A1
(en)
*
|
2011-05-23 |
2012-11-29 |
Shilpa Medicare Limited |
Process for preparing docetaxel trihydrate polymorph
|
|
SI2753355T1
(sl)
|
2011-09-08 |
2019-02-28 |
New York University |
Onkolitični virus herpesa simpleksa in njegove terapevtske uporabe
|
|
WO2013096455A1
(en)
|
2011-12-20 |
2013-06-27 |
Dana-Farber Cancer Institute, Inc. |
Methods for diagnosing and treating oncogenic kras-associated cancer
|
|
KR101809858B1
(ko)
|
2012-04-04 |
2017-12-15 |
할로자임, 아이엔씨 |
항-히알루로난 제제 및 종양-표적 탁산을 이용한 병용 치료
|
|
CA2874521A1
(en)
|
2012-05-24 |
2013-11-28 |
Dana-Farber Cancer Institute, Inc. |
Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
|
|
WO2014014518A1
(en)
|
2012-07-18 |
2014-01-23 |
Dana-Farber Cancer Institute, Inc. |
Methods for treating, preventing and predicting risk of developing breast cancer
|
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
|
WO2014149871A1
(en)
|
2013-03-14 |
2014-09-25 |
Icahn School Of Medicine At Mount Sinai |
Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer
|
|
WO2015050844A1
(en)
|
2013-10-01 |
2015-04-09 |
Dana-Farber Cancer Institute, Inc. |
Methods of treating cancer with atovaquone-related compounds
|
|
US10350264B2
(en)
|
2014-03-27 |
2019-07-16 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin
|
|
MA39818A
(fr)
|
2014-03-30 |
2017-02-08 |
Benevir Biopharm Inc |
Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
|
|
EP3307330B1
(en)
|
2015-06-15 |
2021-03-10 |
New York University |
Method of treatment using oncolytic viruses
|
|
WO2019222435A1
(en)
|
2018-05-16 |
2019-11-21 |
Halozyme, Inc. |
Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
|